X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7235) 7235
Book Review (896) 896
Publication (593) 593
Magazine Article (21) 21
Newsletter (16) 16
Conference Proceeding (12) 12
Book / eBook (10) 10
Book Chapter (10) 10
Dissertation (3) 3
Newspaper Article (2) 2
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6363) 6363
humans (5747) 5747
enterobacteriaceae (2753) 2753
male (2579) 2579
infectious diseases (2563) 2563
female (2531) 2531
microbiology (2467) 2467
enterobacteriaceae infections - drug therapy (2406) 2406
microbial sensitivity tests (2037) 2037
anti-bacterial agents - therapeutic use (1986) 1986
anti-bacterial agents - pharmacology (1985) 1985
enterobacteriaceae - drug effects (1856) 1856
middle aged (1750) 1750
aged (1560) 1560
adult (1552) 1552
enterobacteriaceae infections - microbiology (1508) 1508
pharmacology & pharmacy (1329) 1329
escherichia-coli (1216) 1216
infections (1169) 1169
bacteria (1151) 1151
antibiotics (1150) 1150
klebsiella-pneumoniae (1076) 1076
enterobacteriaceae - isolation & purification (1030) 1030
epidemiology (947) 947
drug resistance (886) 886
beta-lactamases - genetics (872) 872
animals (825) 825
beta-lactamases - metabolism (784) 784
risk factors (781) 781
drug resistance, bacterial (753) 753
prevalence (752) 752
adolescent (747) 747
escherichia coli - drug effects (741) 741
drug resistance in microorganisms (735) 735
resistance (723) 723
health aspects (704) 704
enterobacteriaceae infections - epidemiology (695) 695
escherichia coli (684) 684
research (663) 663
urinary tract infections - drug therapy (650) 650
child (640) 640
aged, 80 and over (630) 630
hospitals (608) 608
antimicrobial resistance (603) 603
drug resistance, microbial (601) 601
drug resistance, multiple, bacterial (601) 601
klebsiella pneumoniae - drug effects (601) 601
abridged index medicus (579) 579
gram-negative bacteria (569) 569
bacteremia (566) 566
risk-factors (565) 565
retrospective studies (562) 562
enterobacteriaceae - enzymology (560) 560
mortality (545) 545
cross infection - microbiology (541) 541
infant (530) 530
klebsiella infections - drug therapy (520) 520
infectious disease (518) 518
immunology (510) 510
treatment outcome (508) 508
child, preschool (506) 506
escherichia coli infections - drug therapy (487) 487
antimicrobial agents (476) 476
beta lactamases (474) 474
infant, newborn (471) 471
urinary tract infections - microbiology (468) 468
e coli (467) 467
escherichia coli - isolation & purification (461) 461
bacterial infections - drug therapy (454) 454
genes (449) 449
klebsiella infections - microbiology (449) 449
carbapenems - pharmacology (444) 444
beta-lactamases - biosynthesis (443) 443
infection (442) 442
beta-lactam resistance (436) 436
enterobacteriaceae - genetics (432) 432
analysis (428) 428
pseudomonas-aeruginosa (424) 424
emergence (420) 420
pneumonia (419) 419
pathogens (418) 418
biochemical phenomena, metabolism, and nutrition (417) 417
escherichia coli infections - microbiology (417) 417
bacterial infections and mycoses (411) 411
bacteremia - microbiology (407) 407
pseudomonas infections - drug therapy (407) 407
klebsiella pneumoniae - isolation & purification (406) 406
cross infection - drug therapy (398) 398
bacterial proteins - genetics (395) 395
nosocomial infections (388) 388
enterobacter (386) 386
cephalosporins - therapeutic use (384) 384
cross infection - epidemiology (378) 378
pseudomonas aeruginosa - drug effects (373) 373
surveillance (368) 368
medicine, general & internal (365) 365
susceptibility (365) 365
bacteremia - drug therapy (356) 356
antibiotic resistance (353) 353
therapy (353) 353
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6577) 6577
French (188) 188
Spanish (129) 129
German (122) 122
Russian (72) 72
Italian (46) 46
Polish (45) 45
Japanese (42) 42
Romanian (19) 19
Turkish (14) 14
Danish (8) 8
Czech (6) 6
Croatian (5) 5
Portuguese (5) 5
Dutch (3) 3
Korean (3) 3
Norwegian (3) 3
Chinese (2) 2
Hebrew (2) 2
Slovak (2) 2
Swedish (2) 2
Ukrainian (2) 2
Bosnian (1) 1
Finnish (1) 1
Icelandic (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 6, pp. 661 - 673
Journal Article
Journal of Infection, ISSN 0163-4453, 2014, Volume 69, Issue 3, pp. 216 - 225
Summary Background An intervention for Gram-negative bloodstream infections that integrated mass spectrometry technology for rapid diagnosis with antimicrobial... 
Infectious Disease | Bloodstream infections | Multidrug resistant | Antimicrobial stewardship | MALDI-TOF | Rapid diagnostics | MORTALITY | ACQUIRED INFECTIONS | INFECTIOUS DISEASES | METAANALYSIS | IDENTIFICATION | DISEASES SOCIETY | IMPACT | THERAPY | HEALTH-CARE | BLOOD-STREAM INFECTIONS | ENTEROBACTERIACEAE | Humans | Middle Aged | Bacteremia - mortality | Male | Pseudomonas Infections - mortality | Gram-Negative Bacterial Infections - microbiology | Time Factors | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Time-to-Treatment | Bacteremia - drug therapy | Klebsiella - enzymology | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas Infections - diagnosis | Survival Rate | Pseudomonas Infections - microbiology | Klebsiella Infections - diagnosis | Gram-Negative Bacterial Infections - diagnosis | Hospital Costs | Escherichia coli Infections - mortality | Pseudomonas aeruginosa - isolation & purification | beta-Lactam Resistance | Acinetobacter Infections - mortality | Klebsiella - isolation & purification | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Adult | Female | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Length of Stay | Escherichia coli Infections - diagnosis | Intensive Care Units | Klebsiella Infections - drug therapy | Acinetobacter Infections - diagnosis | Hospital Mortality | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Treatment Outcome | Bacteremia - diagnosis | Klebsiella Infections - microbiology | Escherichia coli - isolation & purification | Klebsiella Infections - mortality | Aged | Gram-Negative Bacterial Infections - mortality | Drug resistance in microorganisms | Care and treatment | Mass spectrometry | Patient outcomes | Index Medicus
Journal Article
Hepatology, ISSN 0270-9139, 05/2012, Volume 55, Issue 5, pp. 1551 - 1561
Epidemiology, risk factors, and clinical effect of infections by multiresistant bacteria in cirrhosis are poorly known. This work was a prospective evaluation... 
PERITONITIS | LIVER-CIRRHOSIS | ACQUIRED INFECTIONS | ESCHERICHIA-COLI | ACQUISITION | RESISTANCE | HEPATORENAL-SYNDROME | SEPSIS | NORFLOXACIN PROPHYLAXIS | GASTROENTEROLOGY & HEPATOLOGY | KLEBSIELLA-PNEUMONIAE | Multivariate Analysis | Prevalence | Prognosis | Community-Acquired Infections - epidemiology | Gram-Positive Bacteria - drug effects | Humans | Middle Aged | Male | Enterobacteriaceae - isolation & purification | Gram-Negative Bacteria - isolation & purification | Liver Cirrhosis - epidemiology | Microbial Sensitivity Tests | Community-Acquired Infections - drug therapy | Drug Resistance, Multiple, Bacterial | Statistics, Nonparametric | Female | Retrospective Studies | beta-Lactamases - metabolism | Bacterial Infections - microbiology | Cross Infection - epidemiology | Liver Cirrhosis - diagnosis | Bacterial Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Risk Factors | Proportional Hazards Models | Cross Infection - drug therapy | Gram-Negative Bacteria - drug effects | Spain - epidemiology | Cross Infection - microbiology | Bacterial Infections - epidemiology | Enterobacteriaceae - drug effects | Survival Analysis | Gram-Positive Bacteria - isolation & purification | Liver Cirrhosis - microbiology | Aged | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Community-Acquired Infections - microbiology | Cohort Studies | Bacterial infections | Antibiotics | Mortality | Bacteria | Staphylococcus infections | Nosocomial infections | Epidemiology | Index Medicus
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 2, pp. 161 - 168
Journal Article
Infection Control and Hospital Epidemiology, ISSN 0899-823X, 09/2013, Volume 34, Issue 9, pp. 940 - 946
Objective. Urinary tract infections (UTIs) are common among hospitalized patients. Selection of an appropriate antibiotic for this infection requires knowledge... 
Hospitalization rates | Pathogens | Databases | Original Article | Escherichia coli | Urinary tract infections | Hospitalization | Infections | Carbapenems | Klebsiella pneumoniae | Enterobacteriaceae | MORTALITY | INFECTIOUS DISEASES | SINGLE-CENTER EXPERIENCE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ORAL-THERAPY | PYELONEPHRITIS | INTENSIVE-CARE-UNIT | ANTIMICROBIAL THERAPY | ANTIBIOTIC-TREATMENT | PNEUMONIA | NOSOCOMIAL INFECTIONS | PATHOGENS | Escherichia coli Infections - drug therapy | United States - epidemiology | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Humans | Drug Resistance, Bacterial | Escherichia coli Infections - microbiology | Hospitalization - statistics & numerical data | Gram-Negative Bacterial Infections - drug therapy | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cross Infection - drug therapy | Urinary Tract Infections - drug therapy | Gram-Negative Bacterial Infections - microbiology | Escherichia coli Infections - epidemiology | Urinary Tract Infections - epidemiology | Klebsiella Infections - epidemiology | Pseudomonas Infections - epidemiology | Cross Infection - microbiology | Drug Resistance, Multiple, Bacterial | Gram-Negative Bacterial Infections - epidemiology | Urinary Tract Infections - microbiology | Cross Infection - epidemiology | Index Medicus | Nursing
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 03/2016, Volume 193, Issue 5, pp. 504 - 515
Rationale: Cystic fibrosis (CF) is characterized by early structural lung disease caused by pulmonary infections. The nasopharynx of infants is a major... 
Healthy controls | Cystic fibrosis | Microbiota | Nasopharynx | Longitudinal | microbiota | SMALL-COLONY VARIANTS | CARRIAGE | HAEMOPHILUS-INFLUENZAE | COMMUNITIES | CHILDREN | STREPTOCOCCUS-PNEUMONIAE | INHIBITION | RESPIRATORY SYSTEM | cystic fibrosis | INFLAMMATION | LUNG-DISEASE | STAPHYLOCOCCUS-AUREUS | longitudinal | nasopharynx | healthy controls | CRITICAL CARE MEDICINE | Carrier State - epidemiology | Streptococcus mitis - genetics | Prospective Studies | Humans | Corynebacterium Infections - epidemiology | Carrier State - microbiology | Haemophilus Infections - epidemiology | Infant | Male | Corynebacterium Infections - microbiology | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Enterobacteriaceae Infections - epidemiology | Female | Staphylococcal Infections - microbiology | Nasopharynx - microbiology | Real-Time Polymerase Chain Reaction | Burkholderia Infections - microbiology | Haemophilus Infections - drug therapy | Infant, Newborn | Staphylococcus aureus - genetics | Moraxellaceae Infections - epidemiology | Streptococcal Infections - microbiology | Burkholderia - genetics | Staphylococcal Infections - drug therapy | Burkholderia Infections - epidemiology | Cystic Fibrosis - microbiology | Enterobacteriaceae Infections - microbiology | Enterobacteriaceae - genetics | Moraxellaceae Infections - microbiology | Streptococcal Infections - epidemiology | Haemophilus influenzae - genetics | Corynebacterium - genetics | Cystic Fibrosis - epidemiology | Moraxellaceae Infections - drug therapy | DNA, Bacterial - genetics | Staphylococcal Infections - epidemiology | Corynebacterium Infections - drug therapy | Microbiota - genetics | Burkholderia Infections - drug therapy | Haemophilus Infections - microbiology | RNA, Ribosomal, 16S - genetics | Streptococcal Infections - drug therapy | Moraxella - genetics | Cohort Studies | Enterobacteriaceae Infections - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 4/2013, Volume 56, Issue 8, pp. 1101 - 1107
Journal Article
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 09/2018, Volume 320, Issue 10, pp. 984 - 994
IMPORTANCE Extended-spectrum beta-lactamases mediate resistance to third-generation cephalosporins (eg, ceftriaxone) in Escherichia coli and Klebsiella... 
UNITED-STATES | MEDICINE, GENERAL & INTERNAL | EXTENDED-SPECTRUM | CEFEPIME | THERAPY | BACTEREMIA | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | EXTENSION | Escherichia coli Infections - mortality | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Bacteremia - mortality | Ceftriaxone - pharmacology | Male | Cause of Death | Anti-Bacterial Agents - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Anti-Bacterial Agents - adverse effects | Meropenem | Penicillanic Acid - adverse effects | Thienamycins - adverse effects | Penicillanic Acid - analogs & derivatives | Thienamycins - therapeutic use | Escherichia coli Infections - drug therapy | Klebsiella Infections - drug therapy | Piperacillin, Tazobactam Drug Combination | Bacteremia - drug therapy | Piperacillin - adverse effects | Klebsiella Infections - mortality | Aged | Anti-Bacterial Agents - pharmacology | Piperacillin - therapeutic use | Klebsiella | Treatment outcome | Safety and security measures | Tazobactam | Escherichia coli | Patient outcomes | Analysis | Comparative analysis | Risk factors | Bacterial infections | Intravenous administration | Mortality | Clinical trials | Piperacillin-tazobactam | Infections | Ceftriaxone | Drug resistance | Patients | Side effects | Randomization | Cephalosporins | Piperacillin | Drug therapy | Blood diseases | Blood culture | Carbapenems | Index Medicus | Abridged Index Medicus | Original Investigation | Research
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 12/2015, Volume 70, Issue 7, pp. 2133 - 2143
Journal Article